Patent: 11,033,610
✉ Email this page to a colleague
Summary for Patent: 11,033,610
Title: | Injection paradigm for administration of botulinum toxins |
Abstract: | Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine. |
Inventor(s): | Turkel Catherine C., Aurora Sheena K., Brin Mitchell F. |
Assignee: | Allergan, Inc. |
Application Number: | US16564294 |
Patent Claims: | see list of patent claims |
Details for Patent 11,033,610
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Abbvie Inc. | BOTOX COSMETIC | onabotulinumtoxina | For Injection | 103000 | December 09, 1991 | 11,033,610 | 2039-09-09 |
Abbvie Inc. | BOTOX | onabotulinumtoxina | For Injection | 103000 | December 09, 1991 | 11,033,610 | 2039-09-09 |
Ipsen Biopharm Limited | DYSPORT | abobotulinumtoxina | For Injection | 125274 | April 29, 2009 | 11,033,610 | 2039-09-09 |
Merz Pharmaceuticals Gmbh C/o Merz Pharmaceuticals Llc | XEOMIN | incobotulinumtoxina | For Injection | 125360 | July 30, 2010 | 11,033,610 | 2039-09-09 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |